“Demystifying the results obtained through the use of SGLT-2 inhibitor drugs, used by patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás” (2023) Research, Society and Development, 12(12), p. e76121243964. doi:10.33448/rsd-v12i12.43964.